[99mTc(CO)3] - BiotinNTA derivative for tumor pretargeting

Tumor pretargeting using monoclonal antibodies in combination with biotin, labeled with radionuclides, could be useful for cancer diagnosis and treatment. Biotin nitrilrotriacetic acid (BiotinNTA) having functional groups of three -COOH was used as biotin derivative for antibody pretargeting strategies. In this investigation, 99mTc(CO)3-BiotinNTA was prepared to determine its potential use in antibody pretargeting strategies for tumor diagnosis. 99mTc is considered to be ideal radionuclides for the development of radioimaging of tumor. Radiolabeling of the BiotinNTA was performed in PBS buffer (pH=7.4) at 75 .deg. C, 30 min. The radiolabeling efficiency and radiochemical purity were analyzed by a reverse-phase high performance liquid chromatography (RP-HPLC). The radiolabeled complex was tested in vitro for stability in plasma and biological affinity against avidin using magnetic particle seperator in PBS buffer (pH7.4)